Novonix (NVX) Notes Payables (2020 - 2025)

Novonix (NVX) has 6 years of Notes Payables data on file, last reported at $62.1 million in Q4 2025.

• For the quarter ending Q4 2025, Notes Payables rose 96.0% year-over-year to $62.1 million; the trailing twelve-month figure through Dec 2025 stood at $62.1 million (up 96.0% YoY), and the FY2025 full-year result was $62.1 million, up 96.0% from the prior year.
• Notes Payables for Q4 2025 stood at $62.1 million, up from $31.7 million in the prior quarter.
• Across five years, Notes Payables topped out at $62.1 million in Q4 2025 and bottomed at $213351.5 in Q2 2021.
• The 5-year median for Notes Payables is $1.1 million (2022), against an average of $19.2 million.
• The widest annual swing landed in 2021, when Notes Payables advanced 12.84%; it then soared 3555.73% in 2024.
• A 5-year view of Notes Payables shows it stood at $213351.5 in 2021, then surged by 394.88% to $1.1 million in 2022, then retreated by 17.95% to $866278.0 in 2023, then jumped by 3555.73% to $31.7 million in 2024, then jumped by 96.0% to $62.1 million in 2025.
• The last three Notes Payables figures came in at $62.1 million (Q4 2025), $31.7 million (Q4 2024), and $866278.0 (Q4 2023), per Business Quant data.

Peer Comparison